KRENITSKY KEVIN 4
4 · ENZO BIOCHEM INC · Filed Feb 2, 2010
Insider Transaction Report
Form 4
KRENITSKY KEVIN
President, Enzo Clinical Labs
Transactions
- Award
Common Stock, par value $0.01
2010-01-29+6,000→ 17,600 total
Footnotes (1)
- [F1]The Reporting Person was granted 6,000 shares of restricted common stock, par value $0.01 per share, of the Company on January 29, 2010 in connection with his service as an officer of the Company. The shares will vest in three equal annual installments, beginning on January 29, 2011.